A German court on Thursday put on hold a patent trial brought by German biotech firm CureVac against domestic rival BioNTech ...

Pfizer (NYSE: PFE) stock rose more than 3% in value, while BioNTech (NASDAQ: BNTX) leaped nearly 6.5% skyward. Pfizer and ...

BioNTech SE is revising plans to build a manufacturing network of vaccine plants in three countries in Africa, just over a ...

Germany's BioNTech announced on Monday a partnership with a global coalition for up to $90 million in funding to support the ...

BioNTech says it is broadening activities in Africa amid reports the German biopharma is reversing manufacturing plans in the ...

COMIRNATY Omicron XBB.1.5-adapted monovalent COVID-19 vaccine is now authorized in Canada for individuals 6 months of age and olderNew Omicron ...

The Coalition for Epidemic Preparedness Innovations, or CEPI, has pledged up to $90 million to BioNTech’s messenger RNA ...

By Robb M. Stewart Canada's health regulator cleared the latest Covid-19 shot from Pfizer and partner BioNTech, giving its approval to a second ...

The COVID-19 pandemic highlighted a need for local production of vaccines. Now, German pharma company BioNTech has said it ...

CET/CEST The issuer is solely responsible for the content of this announcement. Regional Court Düsseldorf postpones infringement ruling on four intellectual property rights in lawsuit filed by CureVac ...

CEPI will provide funding of up to $90 million to support the development of vaccine candidates which is based on BioNTech's ...

CEPI will provide funding of up to $90 million to support the development of vaccine candidates which is based on BioNTech's ...